ASX Share rice
Tue 27 Oct 2020 - 05:56:pm (Sydney)

LCT Share Price

LIVING CELL TECHNOLOGIES LIMITEDLCTPharmaceuticals, Biotechnology & Life Sciences

LCT Company Information


Living Cell Technologies Limited





GIC Industry:


GIC Sub Industry:



330 Collins Street Melbourne VIC Australia 3000


61 3 8689 9997

CEO & Exec. Director:

Dr. Kenneth Taylor

Chief Financial Officer:

Mr. Daya Uka

Chief Operating Officer:

Dr. Janice Lam

Company Sec.:

Mr. Mark Andrew Licciardo B Bus (Acc), FCIS, GAICD, GradDip CSP, FGIA

Company Overview:

Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in New Zealand. The company's lead product is NTCELL, an alginate coated capsule, which is in clinical trials for the treatment of Parkinson's disease. It also develops LP-003, a peptide drug that reduces caloric intake targeting obesity; and LC-002, a novel calcitonin gene-related peptide antagonist targeting migraine. Living Cell Technologies Limited has a research collaboration agreement with the University of Auckland to identify products that utilize patented novel peptide synthetic chemistry technology for the treatments for obesity and migraine. The company was founded in 1987 and is based in Melbourne, Australia.

LCT Share Price Information

Shares Issued:


Market Capitalisation:


Revenue (TTM):


Revenue Per Share (TTM):


Earnings per Share:


Profit Margin:


Operating Margin (TTM):


Return On Assets (TTM):


Return On Equity (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


Diluted Earnings Per Share (TTM):


LCT CashFlow Statement

CashFlow Date:




Change To Liabilities:


Total Cashflow From Investing Activities:


Net Borrowings:


Net Income:


Total Cash From Operating Activities:


Other Cashflow From Investing Activities:


Capital Expenditures:


LCT Income Statement

Income Date:


Income Before Tax:


Net Income:


Gross Profit:


Operating Income:


Income Tax Expense:


Total Revenue:


LCT Balance Sheet

Balance Sheet Date:


Total Liabilities:


Total Stockholder Equity:


Total Assets:


Common Stock:


Retained Earnings:




Total Current Liabilities:


Property - Plant & Equipment:


Net Tangible Assets:


Long-Term Investments:


Total Current Assets:


Net Receivables:


Short-Term Investments:


Accounts Payable:


Short-Term Investments:


Non Current Liabilities Total:


LCT Share Price History

LCT News

25 Sep, 2020
Ken Taylor has been the CEO of Living Cell Technologies Limited (ASX:LCT) since 2014, and this article will examine...
14 Mar, 2020
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
14 Jan, 2020
Ken Taylor became the CEO of Living Cell Technologies Limited (ASX:LCT) in 2014. This analysis aims first to contrast...
14 Nov, 2019
It's not possible to invest over long periods without making some bad investments. But really big losses can really...